Pharmadrug Inc
F:G11
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharmadrug Inc
F:G11
|
CA |
|
F.C.C. Co Ltd
OTC:FCVFF
|
JP |
Intrinsic Value
The intrinsic value of Pharmadrug Inc (G11) under the Base Case is 0.02 EUR per share. Compared with the current market price of 0.008 EUR, the stock appears Undervalued by 60% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Pharmadrug Does
Pharmadrug, Inc. engages in the research, development, and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally derived approved drugs. The firm is focused on the research, development and commercialization of controlled substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines.
- Headquarters
- Canada CA
- IPO date
- Aug 16, 2018
Earnings Waterfall
Pharmadrug Inc
The intrinsic value for Pharmadrug Inc (G11) under the Base Case is 0.02 EUR.
Compared with the current market price of 0.008 EUR, the stock appears Undervalued by 60% .